Home LiteratureArticle Details
PMID: 3311359 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host.

Cancer research ·Vol. 47 ·No. 22 ·1987-11-15 ·Pages 5919-23

Beck SA, Tisdale MJ

Abstract

Animals given transplants of the MAC16 colon adenocarcinoma show a progressive decrease in carcass weight as the tumor size increases without a reduction in either fluid or caloric intake when compared with non-tumor-bearing controls. There is a decrease in both carcass fat and muscle mass which is directly proportional to the weight of the tumor. In male animals weight loss occurs when the tumor mass comprises more than 0.3% of the body weight and reaches 30% when the tumor represents 3% of the body weight. There is evidence for the production by the tumor of both lipolytic and proteolytic factors, which may be responsible for the cachexia, since two related mouse adenocarcinomas, which do not produce weight loss, have little lipolytic or proteolytic activity. The lipolytic factor is nondialyzable and is destroyed by both heat and acid. Both insulin and 3-hydroxybutyrate suppress the lipolytic activity of the tumor extract. The MAC16 tumor also contains a serine protease, the activity of which is also completely abolished by insulin and 3-hydroxybutyrate. Animals bearing the MAC16 tumor have an elevated plasma lipolytic and proteolytic activity when compared with non-tumor-bearing controls, suggesting a peripheral effect of the tumor products. The catabolic factors elaborated by the MAC16 adenocarcinoma may be responsible for the loss of both the fat and nonfat carcass mass, but they do respond to normal metabolic controls.

MeSH Terms
Adenocarcinoma/physiopathology Animals Body Weight Cachexia/metabolism Cell Line Colonic Neoplasms/physiopathology Kinetics Lipolysis Male Mice Mice, Inbred BALB C Mice, Inbred Strains Peptide Hydrolases/metabolism
Chemicals
Peptide Hydrolases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Beck S A
Pharmaceutical Sciences Institute, Aston University, Birmingham, United Kingdom.
Tisdale M J
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1987-11-15
Pages
5919-23
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com